December 15, 2020
Estevam et al. Clinical Cytometry 2020;100:92-102.
Development and validation of a high-parameter mass cytometry workflow to decipher immunomodulatory changes in celiac disease
You might also be interested by
CellTalk Blog
ELISpot vs. ICS: Optimizing Immune Monitoring in Clinical Trials with the Right Functional Assay
November 19, 2024
Immune Monitoring
More infoCellTalk Blog
Measure Target Engagement With Receptor Occupancy Assays by Flow Cytometry
September 17, 2024
Immune Monitoring
More infoBrochures & Infographics
High Performance Technologies for Cytokine Measurement
July 29, 2024
Immune Monitoring
More info